Doctors

A Message From Our Medical Director

An Intro to Medical Cannabis

Clinical Applications of Medical Cannabis

Shared Care Framework 

Safety, Interactions & Adverse Effects 

Clinical Resources for Practitioners 

Real Patient Outcomes 

Regulatory & Legal Framework 

Our Clinical Team 

Interested in joining the Indra Clinical Network? 

GP FAQs

A Message from Our Medical Director 

“At Indra, we believe in advancing the practice of medicine through scientific integrity, patient-centred design and responsible innovation.


Our ethos is rooted in evidence-based practice, multidisciplinary collaboration and safeguarding patients. We aim to build long-term therapeutic relationships that prioritise safety, trust and wellbeing.


We aim to empower clinicians with the knowledge and frameworks to safely incorporate emerging therapies, such as cannabinoid-based medicines (CBPM), into holistic, measurable treatment models.


Medical cannabis is not a “cure all”, but is a legitimate and potentially life-changing tool when embedded in proper clinical care. We view it not as an isolated intervention, but as one potential tool within a broader psycho-social framework.


Each patient journey is grounded in diagnostics, evidence and long-term outcomes. We believe the best patient outcomes come not just from what we prescribe, but how we listen, how we empower and how we work as a team. To this end, we have regular MDTs with a cross-functional team of health and wellness practitioners.


I have been a Consultant in Palliative Medicine for 35 years and have a long-standing interest in holistic, person-centred care. I have seen the limitations of conventional treatments and the unmet need of patients navigating complex pain, psychological distress and quality of life challenges.


Within the clinic, my priorities are to ensure that our governance systems are robust, our prescribing protocols are clinically responsible and our mandatory communication with GPs and external teams is transparent and timely. We emphasise education, informed consent and value continuity of care throughout the patient journey.”

Dr. Sheila Popert BDS (Hons) LRCP MRCS

Medical Director – Indra Clinic

A Message From Our Medical Director

An Intro to Medical Cannabis

Clinical Applications of Medical Cannabis

Shared Care Framework 

Safety, Interactions & Adverse Effects 

Clinical Resources for Practitioners 

Real Patient Outcomes 

Regulatory & Legal Framework 

Our Clinical Team 

Interested in joining the Indra Clinical Network? 

GP FAQs

A Message from Our Medical Director 

“At Indra, we believe in advancing the practice of medicine through scientific integrity, patient-centred design and responsible innovation.


Our ethos is rooted in evidence-based practice, multidisciplinary collaboration and safeguarding patients. We aim to build long-term therapeutic relationships that prioritise safety, trust and wellbeing.


We aim to empower clinicians with the knowledge and frameworks to safely incorporate emerging therapies, such as cannabinoid-based medicines (CBPM), into holistic, measurable treatment models.


Medical cannabis is not a “cure all”, but is a legitimate and potentially life-changing tool when embedded in proper clinical care. We view it not as an isolated intervention, but as one potential tool within a broader psycho-social framework.


Each patient journey is grounded in diagnostics, evidence and long-term outcomes. We believe the best patient outcomes come not just from what we prescribe, but how we listen, how we empower and how we work as a team. To this end, we have regular MDTs with a cross-functional team of health and wellness practitioners.


I have been a Consultant in Palliative Medicine for 35 years and have a long-standing interest in holistic, person-centred care. I have seen the limitations of conventional treatments and the unmet need of patients navigating complex pain, psychological distress and quality of life challenges.


Within the clinic, my priorities are to ensure that our governance systems are robust, our prescribing protocols are clinically responsible and our mandatory communication with GPs and external teams is transparent and timely. We emphasise education, informed consent and value continuity of care throughout the patient journey.”

Dr. Sheila Popert BDS (Hons) LRCP MRCS

Medical Director – Indra Clinic